Education
About Us
Working with TipRanks
Follow Us
CSTK - ETF AI Analysis
Top Page
Invesco Comstock Contrarian Equity ETF (CSTK)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several top holdings, including Alphabet, Johnson Controls, and Wells Fargo, have delivered strong year-to-date performance, supporting the fund's overall returns.
Sector Diversification
The ETF is spread across ten sectors, reducing the risk of a downturn in any single industry.
Reasonable Expense Ratio
The fund's expense ratio is relatively low, making it cost-effective compared to many actively managed funds.
Negative Factors
Heavy U.S. Focus
With over 98% of assets in U.S. companies, the ETF lacks global diversification and is sensitive to domestic market conditions.
Underperforming Holding
Merck & Company has shown negative year-to-date performance, which could drag on the fund's overall returns.
High Financial Sector Exposure
The fund has significant exposure to the financial sector, which could be risky if the sector faces challenges.
CSTK vs. SPDR S&P 500 ETF (SPY)
AUM110.38M
RegionGlobal
Expense Ratio0.35%
Beta0.79
IssuerInvesco
Inception DateMay 07, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume310
30 Day Avg. Volume3,097
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.75Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering53
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CSTK Summary
The Invesco Comstock Contrarian Equity ETF (CSTK) is an actively managed fund that focuses on finding undervalued companies across various industries, primarily in the U.S. It includes well-known names like Bank of America and Microsoft, along with others in sectors such as financials, healthcare, and technology. This ETF is designed for investors who want to explore hidden opportunities in the market and aim for both growth and income through a value-focused strategy. However, since CSTK invests in companies that may be out of favor, their stock prices can be more volatile, and returns may take time to materialize.
How much will it cost me?The Invesco Comstock Contrarian Equity ETF (CSTK) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it’s actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The CSTK ETF could benefit from a global economic recovery, which may boost undervalued companies across sectors like financials, healthcare, and technology, where it has significant exposure. However, rising interest rates or regulatory changes in key sectors like financials and healthcare could negatively impact its holdings, while global economic uncertainty might weigh on its contrarian investment strategy. Its focus on undervalued companies provides potential for growth but also carries risks if market conditions remain unfavorable.
CSTK Top 10 Holdings
The Invesco Comstock Contrarian Equity ETF (CSTK) leans heavily into financials, with Bank of America and Wells Fargo driving steady gains thanks to strong earnings momentum and attractive valuations. Alphabet’s rising performance, fueled by its AI and cloud investments, adds a tech edge to the fund, while Merck’s steady pipeline advancements bolster the healthcare exposure. On the flip side, Chevron’s lagging performance amid bearish technical signals and Microsoft’s mixed outlook weigh slightly on returns. With a global focus and a value-driven strategy, CSTK offers a diversified yet sector-heavy portfolio that balances opportunity with risk.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Bank of America | 4.20% | $4.63M | $410.18B | 26.68% | 72 Outperform | |
| Alphabet Class A | 4.02% | $4.43M | $3.79T | 62.64% | 85 Outperform | |
| Wells Fargo | 3.67% | $4.04M | $299.03B | 33.96% | 80 Outperform | |
| Cisco Systems | 3.23% | $3.56M | $308.82B | 31.12% | 77 Outperform | |
| Merck & Company | 3.20% | $3.52M | $265.03B | 7.10% | 80 Outperform | |
| CVS Health | 3.05% | $3.36M | $101.06B | 78.94% | 64 Neutral | |
| Chevron | 3.02% | $3.33M | $302.07B | 4.18% | 71 Outperform | |
| State Street | 2.95% | $3.25M | $36.95B | 34.18% | 75 Outperform | |
| Johnson Controls | 2.78% | $3.06M | $74.60B | 52.92% | 70 Outperform | |
| Microsoft | 2.78% | $3.06M | $3.62T | 13.28% | 79 Outperform |
CSTK Technical Analysis
Positive
―
Price Trends
28.26
Positive
27.91
Positive
Market Momentum
0.32
Negative
67.75
Neutral
63.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CSTK, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.90, equal to the 50-day MA of 28.26, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.32 indicates Negative momentum. The RSI at 67.75 is Neutral, neither overbought nor oversold. The STOCH value of 63.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CSTK.
CSTK Peer Comparison
Comparison Results
Performance Comparison
CSTK
Invesco Comstock Contrarian Equity ETF
29.37
4.61
18.62%
FEGE
First Eagle Global Equity ETF
―
―
―
BKDV
BNY Mellon Dynamic Value ETF
―
―
―
FPAG
FPA Global Equity ETF
―
―
―
GMOI
GMO International Value ETF
―
―
―
MFSV
MFS Active Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents